Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese

Citation
Jd. Huang et al., Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese, DRUG META D, 27(1), 1999, pp. 98-101
Citations number
35
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG METABOLISM AND DISPOSITION
ISSN journal
00909556 → ACNP
Volume
27
Issue
1
Year of publication
1999
Pages
98 - 101
Database
ISI
SICI code
0090-9556(199901)27:1<98:DOANCP>2.0.ZU;2-Z
Abstract
Despite a wide interindividual variation of cytochrome P-450 1A2 (CYP1A2) a ctivity, genetic polymorphism of CYP1A2 has not been reported. By amplifica tion of exons of CYP1A2 by polymerase chain reaction in eight Chinese subje cts, the polymerase chain reaction products were directly sequenced. One su bject showed heterozygous C-2866-->G (Phe(21)-->Leu) polymorphism. DNA from 157 Chinese subjects (104 polychlorinated biphenyl-exposed subjects and 53 control subjects) was screened for polymorphism by single-strand conformat ion polymorphism method and Mboll endonuclease digestion. Only 1 of 157 sam ples showed another heterozygous C-2866-->G mutation. The subject was previ ously exposed to polychlorinated biphenyl and showed a value of 3.5% in the caffeine breath test. The value is not significantly higher than the mean value of polychlorinated biphenyl-exposed subjects (3.12 +/- 0.29%, mean +/ - S.E.M.). The incidence of the point mutation in these Chinese subjects is less than 1%. The prevalence of the F21L mutation in other ethnic groups a nd its effect on the metabolic activity of CYP1A2 remain to be further eval uated.